glp 1 and gip receptors Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes GLP-1 Receptor Agonists Explained for

Activity-balanced GLP-1/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates

Wadden TA, Tronieri JS, Butryn ML

In this article, we will review incretin physiology and evidence supporting a role of the incretin hormones in the pathophysiology of hyperinsulinemic hypoglycemia, as well as results from proof-of concept studies exploring a therapeutic approach targeting the GLP-1 receptor to treat hyperinsulinemic hypoglycemia

For instance, in the SUSTAIN-6 trial, semaglutide was associated with a significantly higher ratio of retinopathy complications compared with placebo, including vitreous hemorrhage, retinal photocoagulation, and intravitreal therapy